GTS Securities’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

GTS Securities’s Portfolio LABD Stock Details LABD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$690K	Sell	42,361 -152	-0.4%	-$2.88K	0.02%	553
2025 Q4	$895K	Buy	+42,513	New	+$1.15M	0.03%	488
2025 Q3	–	Sell	-2,033	Closed	-$152K	–	1601
2025 Q2	$152K	Buy	+2,033	New	+$180K	0.01%	1141
2025 Q1	–	Sell	-3,536	Closed	-$256K	–	1441
2024 Q4	$256K	Sell	3,536 -4,877	-58%	-$298K	0.01%	976
2024 Q3	$491K	Buy	8,413 +3,699	+78%	+$225K	﹤0.01%	2841
2024 Q2	$346K	Sell	4,714 -4,588	-49%	-$387K	﹤0.01%	3004
2024 Q1	$678K	Buy	9,302 +5,426	+140%	+$453K	﹤0.01%	2309
2023 Q4	$376K	Sell	3,876 -812	-17%	-$158K	﹤0.01%	3022
2023 Q3	$966K	Buy	4,688 +1,961	+72%	+$319K	﹤0.01%	2041
2023 Q2	$392K	Buy	+2,727	New	+$407K	0.01%	765

Other funds holding LABD

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

CCM

Capstone Capital Management Hong Kong $224M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

GTS Securities's LABD Position: Q1 2026 in Review

GTS Securities reduced its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 0.36% in Q1 2026, selling an estimated $2.88K and leaving 42,361 shares worth $690K. The position accounts for 0.02% of the portfolio, ranked #553.

GTS Securities first reported a position in LABD in Q2 2023 and has held it in 10 quarters since. The position peaked at $966K in Q3 2023. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

GTS Securities held 42,361 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $690K as of Q1 2026.
GTS Securities sold 152 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $2.88K.
Direxion Daily S&P Biotech Bear 3X ETF made up 0.02% of GTS Securities's portfolio in Q1 2026, its #553 holding.
GTS Securities first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2023 and has held it in 10 quarters since.
GTS Securities's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $966K in Q3 2023.
17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.